Skip to content

Clinical trials

Atrial Fibrillation trials in the Netherlands with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Not applicable Country / region: Netherlands Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20062
20073
20081
20092
20103
20114
20127
20133
20145
20156
20166
20172
20183
20197
20206
20217
20224
20237
202410
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Terminated17
Recruiting11
Active, not recruiting9
Not yet recruiting4
Unknown status3
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices13
Maastricht University Medical Center9
University Medical Center Groningen7
Boston Scientific Corporation6
Medtronic Cardiac Rhythm and Heart Failure5
Adagio Medical4
Medisch Spectrum Twente4
AtriCure, Inc.3
R&D Cardiologie3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation102
Heart Failure11
Stroke8
Arrhythmias, Cardiac7
Atrial Flutter5
Coronary Artery Disease3
Cardiovascular Diseases2
Hemorrhage2
Ischemic Stroke2
Diabetes Mellitus1

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.